IGC Pharma, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.185 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 19.13M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer’s disease in the United States and Colombia. The company’s lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer’s. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer’s disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Details
| Name | IGC Pharma, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 70 |
| Founded | 2005 |
| Ceo | Ram Mukunda |
| Country | United States |
| Exchange | NYSEAMERICAN |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| Isin | US45408X3089 |
| Cusip | 45408X308 |
| Cik | 1326205 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Ram Mukunda | Founder, President, Chief Executive Officer and Director |
| Claudia Grimaldi | Vice President, Principal Financial Officer, Chief Compliance Officer and Non-Independent Director |
| Benysh Qureshi Esq., M.B.A. | Director of Operations |
| Rohit Goel CPA, M.B.A. | Director of Accounting and Senior Director |
Contact
| Address | 10224 Falls Road, Potomac, Maryland 20854, United States |
| Phone | 301 983 0998 |
| Website | https://igcpharma.com |